Di V erential expression of CD 44 v 6 in metastases of intestinal and di V use types of gastric carcinoma
暂无分享,去创建一个
[1] P. Herrlich,et al. CD44 variant exon epitopes in primary breast cancer and length of survival , 1995, The Lancet.
[2] S. Fox,et al. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. , 1994, Cancer research.
[3] C. Figdor,et al. De-novo expression of CD44 and survival in gastric cancer , 1993, The Lancet.
[4] F M van den Berg,et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. , 1993, Cancer research.
[5] H. Müller-Hermelink,et al. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. , 1993, Cancer research.
[6] P. Herrlich,et al. CD44 splice variants: metastases meet lymphocytes. , 1993, Immunology today.
[7] P. Herrlich,et al. Prevention of tumor metastasis formation by anti-variant CD44 , 1993, The Journal of experimental medicine.
[8] Martin Hofmann,et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.
[9] L. Picker,et al. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types , 1989, The Journal of cell biology.